Home › Therapeutic areas › Infectious Disease › Hepatitis C
Hepatitis C (1 companies)
Companies with an active program in Hepatitis C.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals | DermatologyImmunology+1 | 1 | Approved | $320M | 7 |
No companies match.